132 A 3 months course of long acting repeatable octreotide (sandostatin-LAR) reduces portal pressure in patients with cirrhosis. A double-blind randomized controlled trial

✍ Scribed by Laurent Spahr; Jean-Louis Frossard; Emiliano Giostra; Gilles Mentha; Antoine Hadengue

• Book ID: 119530041
• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 181 KB
• Volume: 38
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1016/s0270-9139(03)80175-1